# A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre

> **NCT05058937** · NA · RECRUITING · sponsor: **The Belgian Society of Medical Oncology** · enrollment: 936 (estimated)

## Conditions studied

- Solid Tumor
- Metastatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Comprehensive genomic profiling

## Key facts

- **NCT ID:** NCT05058937
- **Lead sponsor:** The Belgian Society of Medical Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-01
- **Primary completion:** 2023-05
- **Final completion:** 2026-05
- **Target enrollment:** 936 (ESTIMATED)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05058937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05058937, "A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05058937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*